Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News

Stem Cell Tourism Hardly a Vacation 



Stem Cell Tourism Hardly a Vacation

August 16, 2012 - (GEN) - "A July 23 federal court decision allows the agency to regulate as drugs clinical treatments produced from patients’ stem cells processed beyond “minimal” manipulation. The U.S. District Court in Washington, DC, upheld an FDA injunction shutting down Regenerative Sciences, contending its Regenexx-C stem-cell therapy entails more-than- “minimal” manipulation and is thus a drug requiring agency approval."  Read Full Article


Posted on 23-Aug-12 by Toto, Brent
Tags: Science and Industry News
Trackback Url  |  Link to this post | Bookmark this post with: